Cargando…
Cancer stem cells and HER2 positive breast cancer: The story so far
Human Epidermal Growth Factor Receptor type 2 (HER2) gene amplification and/or protein overexpression is observed in patients suffering from HER2+ breast cancer. This subtype of breast cancer has improved prognosis due to availability of anti-HER2 therapy. However, drug resistance and tumor recurren...
Autores principales: | Shah, Deep, Osipo, Clodia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095671/ https://www.ncbi.nlm.nih.gov/pubmed/30123819 http://dx.doi.org/10.1016/j.gendis.2016.02.002 |
Ejemplares similares
-
Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer
por: Baker, Andrew T., et al.
Publicado: (2014) -
Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
por: Nguyen, Mai, et al.
Publicado: (2022) -
Dose-dense chemotherapy for breast cancer: the story so far
por: Hudis, C
Publicado: (2000) -
Stem Cell Therapy for Burns: Story so Far
por: Abdul Kareem, Najath, et al.
Publicado: (2021) -
Notch Signaling in Breast Cancer: A Role in Drug Resistance
por: BeLow, McKenna, et al.
Publicado: (2020)